The latest and greatest new biomarkers - Which ones should we measure for risk prediction in our practice?

被引:9
作者
de Lemos, James A. [1 ]
机构
[1] Univ Texas SW Med Ctr, Dallas, TX 75390 USA
关键词
D O I
10.1001/archinte.166.22.2428
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2428 / 2430
页数:3
相关论文
共 17 条
  • [11] Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease
    Morrow, DA
    de Lemos, JA
    Blazing, MA
    Sabatine, MS
    Murphy, SA
    Jarolim, P
    White, HD
    Fox, KAA
    Califf, RM
    Braunwald, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (22): : 2866 - 2871
  • [12] Clinical relevance of C-reactive protein during follow-up of patients with acute coronary syndromes in the Aggrastat-to-Zocor Trial
    Morrow, David A.
    de Lemos, James A.
    Sabatine, Marc S.
    Wiviott, Stephen D.
    Blazing, Michael A.
    Shui, Amy
    Rifai, Nader
    Califf, Robert M.
    Braunwald, Eugene
    [J]. CIRCULATION, 2006, 114 (04) : 281 - 288
  • [13] Markers of inflammation and cardiovascular disease application to clinical and public health practice - A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association
    Pearson, TA
    Mensah, GA
    Alexander, RW
    Anderson, JL
    Cannon, RO
    Criqui, M
    Fadl, YY
    Fortmann, SP
    Hong, Y
    Myers, GL
    Rifai, N
    Smith, SC
    Taubert, K
    Tracy, RP
    Vinicor, F
    [J]. CIRCULATION, 2003, 107 (03) : 499 - 511
  • [14] Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies
    Romero-Corral, Abel
    Montori, Victor M.
    Somers, Virend K.
    Korinek, Josef
    Thomas, Randal J.
    Allison, Thomas G.
    Mookadam, Farouk
    Lopez-Jimenez, Francisco
    [J]. LANCET, 2006, 368 (9536) : 666 - 678
  • [15] Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease
    Rothenbacher, Dietrich
    Koenig, Wolfgang
    Brenner, Hermann
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (22) : 2455 - 2460
  • [16] Analysis of N-terminal-pro-brain natriuretic peptide and C-reactive protein for risk stratification in stable and unstable coronary artery disease:: results from the AtheroGene study
    Schnabel, R
    Rupprecht, HJ
    Lackner, KJ
    Lubos, E
    Bickel, C
    Meyer, J
    Münzel, T
    Cambien, F
    Tiret, L
    Blankenberg, S
    [J]. EUROPEAN HEART JOURNAL, 2005, 26 (03) : 241 - 249
  • [17] Plasma natriuretic peptide levels and the risk of cardiovascular events and death
    Wang, TJ
    Larson, MG
    Levy, D
    Benjamin, EJ
    Leip, EP
    Omland, T
    Wolf, PA
    Vasan, RS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (07) : 655 - 663